International Publications Archive - Seite 11 von 223 - IOZK

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus

2022-02-28/in International Publications, Newcastle Disease Virus /von 2022-02-28 / Biomedicines 2022 Feb;10(3)

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

2022-02-16/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;

Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma

2022-02-15/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737

Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis

2022-02-04/in Dendritic Cells, Glioblastoma, International Publications /von 2022-02-04 / Curr Oncol 2022 Feb;29(2):881-891

Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients

2022-01-27/in Cervical Cancer, Hyperthermia, International Publications /von 2022-01-27 / Cancers (Basel) 2022 Jan;14(3)

Research progress on dendritic cell vaccines in cancer immunotherapy

2022-01-24/in Dendritic Cells, International Publications /von 2022-01-24 / Exp Hematol Oncol 2022 Jan;11(1):3

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

2022-01-19/in Dendritic Cells, Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-01-19 / Genes Immun 2022 02;23(1):1-11

GP96 and SMP30 Protein Priming of Dendritic Cell Vaccination Induces a More Potent CTL Response against Hepatoma

2022-01-07/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-01-07 / J Healthc Eng 2022;2022:2518847

Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence

2022-01-06/in Breast Cancer, Dendritic Cells, International Publications /von 2022-01-06 / Expert Rev Vaccines 2022 Mar;21(3):337-353

A Single-Arm Phase II Study to Evaluate Efficacy and Safety of First-Line Treatment With DCVAC/LuCa, Standard of Care Chemotherapy and Shenqi Fuzheng Injection in Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer Patients

2022-01-01/in Dendritic Cells, International Publications, NSCLC /von 2022-01-01 / Integr Cancer Ther 2022;21:15347354221083968